Literature DB >> 33224851

The diversities in thyroid cytopathology practices among Asian countries using the Bethesda system for reporting thyroid cytopathology.

Truong Phan Xuan Nguyen1, Vien Thanh Truong2, Kennichi Kakudo3, Huy Gia Vuong4,5.   

Abstract

BACKGROUND: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has been adopted and widely used among Asian countries. This study aims to investigate the application of TBSRTC in thyroid cytology practice among Asian countries.
METHODS: We searched electronic databases including PubMed and Web of Science from 2010 to 2019. Meta-analysis of proportion and their 95% confidence intervals (CIs) were calculated using the random-effect model. Meta-regression and subgroup analysis were used to search for heterogeneity origins.
RESULTS: We included 42 Asian studies with 84.953 fine-needle aspirations. Among six categories, benign was the most commonly diagnosed category. The resection rate (RR) and risk of malignancy (ROM) were highest in malignant and SM categories, and lowest among benign nodules. Thyroid cytology practice in Asia was characterized by a low RR and high ROM in patients with indeterminate thyroid nodules. There was a significant amount of heterogeneities of TBSRTC outputs (frequency, resection rate, and malignancy risk) among Asian countries. Meta-regression showed that the sources of heterogeneity might stem from the differences in study origin and the application of molecular testing. We highlighted the usefulness of preoperative molecular testing to select patients for surgery.
CONCLUSIONS: Our study provided insight regarding thyroid cytology practice among Asian countries. Active surveillance is commonly used in Asian practice resulting in a low RR and high ROM for indeterminate nodules. There are still variations in general thyroid cytology practice in Asia. Future guidelines and consensus regarding the application of TBSRTC in thyroid cytology practice among Asian countries are required. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Asia; The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC); cytology; fine-needle aspiration (FNA); resection rate; risk of malignancy (ROM); thyroid

Year:  2020        PMID: 33224851      PMCID: PMC7667101          DOI: 10.21037/gs-20-404

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  68 in total

1.  Preoperative diagnosis of thyroid nodules using the Bethesda System for Reporting Thyroid Cytopathology: a comprehensive review and meta-analysis.

Authors:  Brandon S Sheffield; Hamid Masoudi; Blair Walker; Sam M Wiseman
Journal:  Expert Rev Endocrinol Metab       Date:  2014-02-17

2.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Modifications in the papillary thyroid cancer gene profile over the last 15 years.

Authors:  Cristina Romei; Laura Fugazzola; Efisio Puxeddu; Francesco Frasca; David Viola; Marina Muzza; Sonia Moretti; Maria Luisa Nicolosi; Carlotta Giani; Valentina Cirello; Nicola Avenia; Stefania Rossi; Paolo Vitti; Aldo Pinchera; Rossella Elisei
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

4.  CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.

Authors:  Huy Gia Vuong; Thao T K Tran; Andrey Bychkov; Chan Kwon Jung; Tadao Nakazawa; Kennichi Kakudo; Ryohei Katoh; Tetsuo Kondo
Journal:  Endocr Pract       Date:  2019-01-18       Impact factor: 3.443

5.  A follow-up study on thyroid aspirates reported as atypia of undetermined significance/follicular lesion of undetermined significance and follicular neoplasm/suspicious for follicular neoplasm: A multicenter study from the Arabian Gulf region.

Authors:  Mousa A Al-Abbadi; Sameera Q Shareef; Mohammad M Yousef; Nidal M Almasri; Huda E Mustafa; Hameed Aljawad; Jassim A Ali; Alan Groves; Yasmen Alsaihati
Journal:  Diagn Cytopathol       Date:  2017-09-01       Impact factor: 1.582

6.  Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.

Authors:  Young Jun Choi; Jung Hwan Baek; Eun Ju Ha; Hyun Kyung Lim; Jeong Hyun Lee; Jae Kyun Kim; Dong Eun Song; Young Kee Shong; Suck Joon Hong
Journal:  Thyroid       Date:  2014-01-15       Impact factor: 6.568

7.  Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand.

Authors:  Yotsapon Thewjitcharoen; Siriwan Butadej; Soontaree Nakasatien; Phawinpon Chotwanvirat; Sriurai Porramatikul; Sirinate Krittiyawong; Nampetch Lekpittaya; Thep Himathongkam
Journal:  J Clin Transl Endocrinol       Date:  2018-12-14

8.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.

Authors:  Yu-zhi Zhang; Ting Xu; Dai Cui; Xiao Li; Qing Yao; Hai-yan Gong; Xiao-yun Liu; Huan-huan Chen; Lin Jiang; Xin-hua Ye; Zhi-hong Zhang; Mei-ping Shen; Yu Duan; Tao Yang; Xiao-hong Wu
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

Review 10.  Thyroid Cytology: The Japanese System and Experience at Yamashita Thyroid Hospital.

Authors:  Shinya Satoh; Hiroyuki Yamashita; Kennichi Kakudo
Journal:  J Pathol Transl Med       Date:  2017-10-11
View more
  1 in total

1.  Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.

Authors:  Chunfang Hu; Weiwei Jing; Qing Chang; Zhihui Zhang; Zhenrong Liu; Jian Cao; Linlin Zhao; Yue Sun; Cong Wang; Huan Zhao; Ting Xiao; Huiqin Guo
Journal:  Mol Oncol       Date:  2022-03-12       Impact factor: 7.449

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.